Skip to content

HGH (Somatropin)

Human Growth Hormone (HGH), also known as somatropin or somatotropin, is a 191 amino acid single-chain polypeptide hormone naturally produced by the anterior pituitary gland.

View research
Limited Research

Livagen

Livagen is a synthetic tetrapeptide with the verified sequence Lys-Glu-Asp-Ala (KEDA), developed by Vladimir Khavinson and colleagues at the St.

View research

Melanotan I

Melanotan I (afamelanotide) is a synthetic analog of α-melanocyte stimulating hormone that selectively targets MC1 receptors to stimulate melanin production.

View research
Well Researched

MK-677

MK-677 (Ibutamoren) is a selective ghrelin receptor agonist that stimulates growth hormone release without suppressing natural production.

View research
Extensively Studied

MOTS-c

MOTS-c is a 16-amino acid mitochondrial-derived peptide encoded by the mitochondrial genome.

View research
Extensively Studied

NAD+

Nicotinamide Adenine Dinucleotide (NAD+) is a vital coenzyme found in every cell that plays a crucial role in energy production, DNA repair, and cellular metabolism.

View research
Limited Research

Ovagen

Ovagen is a synthetic tripeptide with the sequence Glu-Asp-Leu (EDL), developed by Vladimir Kh.

View research
Well Researched

Pinealon

Pinealon (Glu-Asp-Arg/EDR) is a synthetic tripeptide bioregulator developed in Russia that demonstrates unique DNA-interaction capabilities for neuroprotection and cognitive enhancement.

View research
Emerging Research

PNC-27

PNC-27 is a 32-amino acid chimeric anticancer peptide developed in 2000 by Dr.

View research
Limited Research

Prostamax

Prostamax (Lys-Glu-Asp-Pro/KEDP) is a synthetic tetrapeptide bioregulator from the Khavinson peptide family that demonstrates prostate-specific tissue effects.

View research
Well Researched

Sermorelin

Sermorelin acetate is a 29-amino acid synthetic analog of human growth hormone-releasing hormone (GHRH) originally FDA-approved in 1997 for pediatric growth hormone deficiency.

View research
Emerging Research

SLU-PP-332

SLU-PP-332 is a groundbreaking synthetic small-molecule compound developed at Saint Louis University that functions as a pan-estrogen-related receptor (ERR) agonist with preferential activity at ERRα.

View research